Logo

American Heart Association

  32
  0


Final ID:

Treatment Options for Functional MR: From ADVANCED GDMT to Surgery – What Does the Evidence Show?

  • Butler, Javed  ( Baylor Scott and White Research , Dallas , Texas , United States )
  • Author Disclosures:
    Javed Butler: DO have relevant financial relationships ; Consultant:Abbott :Active (exists now) ; Consultant:Daxor, Diastol, Edwards, Element Sciences, Faraday, Idorsia, Impulse Dynamics, Imbria, Innolife, Intellia, Inventiva, Levator, Lexicon, Eli Lilly, Mankind, Medtronic, Merck, New Amsterdam, Novartis, NovoNordisk, Pfizer, Pharmacosmos, Pharmain, Prolaio, Pulnovo, Regeneron, Renibus, Reprieve, Roche, Rycarma, Saillent, Salamandra, Salubris, SC Pharma, SQ Innovation, Secretome, Sequanna, Transmural, TekkunLev, Tenex, Tricog, Ultromic, Vera, Zoll:Active (exists now) ; Consultant:Cytokinetics:Active (exists now) ; Consultant:CVRx:Active (exists now) ; Consultant:CSL Vifor:Active (exists now) ; Consultant:Cardior:Active (exists now) ; Consultant:Cardiac Dimension:Active (exists now) ; Consultant:Bristol Myers Squibb:Active (exists now) ; Consultant:Boehringer Ingelheim:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:AstraZeneca:Active (exists now) ; Consultant:AskBio:Active (exists now) ; Consultant:Amgen:Active (exists now) ; Consultant:American Regent:Active (exists now) ; Consultant:Adaptyx:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

TCT at AHA: Heart Team in Action: Secondary MR: Still a Management Conundrum

Monday, 11/10/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

You have to be authorized to contact abstract author. Please, Login
Not Available